Literature DB >> 1633062

Antimalarial pharmacokinetics and treatment regimens.

N J White1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1633062      PMCID： PMC1381368          DOI： 10.1111/j.1365-2125.1992.tb04100.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  53 in total

1.  Combination treatment for falciparum prophylaxis.

Authors:  N J White
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

2.  Disposition of oral quinine in acute falciparum malaria.

Authors:  W Supanaranond; T M Davis; S Pukrittayakamee; K Silamut; J Karbwang; P Molunto; L Chanond; N J White
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  The pharmacokinetic properties of intramuscular quinine in Gambian children with severe falciparum malaria.

Authors:  D Waller; S Krishna; C Craddock; D Brewster; A Jammeh; D Kwiatkowski; J Karbwang; P Molunto; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jul-Aug       Impact factor: 2.184

Review 4.  Clinical pharmacokinetics of mefloquine.

Authors:  J Karbwang; N J White
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 5.  Metabolism of antimalarial sesquiterpene lactones.

Authors:  I S Lee; C D Hufford
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

6.  Parenteral sulphadoxine-pyrimethamine (Fansidar): an effective and safe but under-used method of anti-malarial treatment.

Authors:  L A Salako; R A Adio; A Sowunmi; O Walker
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Sep-Oct       Impact factor: 2.184

7.  Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.

Authors:  G W Mihaly; S A Ward; G Edwards; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

8.  A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil.

Authors:  W M Watkins; J D Chulay; D G Sixsmith; H C Spencer; R E Howells
Journal:  J Pharm Pharmacol       Date:  1987-04       Impact factor: 3.765

9.  Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.

Authors:  K D Miller; H O Lobel; R F Satriale; J N Kuritsky; R Stern; C C Campbell
Journal:  Am J Trop Med Hyg       Date:  1986-05       Impact factor: 2.345

10.  Complications of quinine poisoning.

Authors:  M E Boland; S M Roper; J A Henry
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321
View more
  36 in total

Review 1.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

2.  Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure.

Authors:  Katherine Winter; Ian M Hastings
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

Review 3.  Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

Authors:  N J White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.

Authors:  N J White; M van Vugt; F Ezzet
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

5.  Antimalarial drug resistance and combination chemotherapy.

Authors:  N White
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

6.  The de novo selection of drug-resistant malaria parasites.

Authors:  N J White; W Pongtavornpinyo
Journal:  Proc Biol Sci       Date:  2003-03-07       Impact factor: 5.349

Review 7.  Antimalarial drug resistance.

Authors:  Nicholas J White
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania.

Authors:  Abdunoor M Kabanywanyi; Christian Lengeler; Prudensiana Kasim; Said King'eng'ena; Raymond Schlienger; Nathan Mulure; Blaise Genton
Journal:  Malar J       Date:  2010-02-11       Impact factor: 2.979

Review 9.  Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010.

Authors:  Neelima Mishra; Jai Prakash Narayan Singh; Bina Srivastava; Usha Arora; Naman K Shah; S K Ghosh; R M Bhatt; S K Sharma; M K Das; Ashwani Kumar; Anupkumar R Anvikar; Kamlesh Kaitholia; Ruchi Gupta; G S Sonal; A C Dhariwal; Neena Valecha
Journal:  Bull World Health Organ       Date:  2012-10-31       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.